Skip to content
10-K

Annual Report

Krystal Biotech, Inc. KRYS

0001711279-26-000016

← back to feed
Filed
Feb 17, 2026 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Feb 11, 2026 29.23M sh
Shares Diluted FY 2025 · Dec 31, 2025 29.95M sh
Shares Diluted FY 2025 · Dec 31, 2024 29.74M sh
Shares Diluted restated FY 2025 · Dec 31, 2023 27.75M sh
Capex FY 2025 · Dec 31, 2025 $11.95M
Capex FY 2025 · Dec 31, 2024 $4.24M
Capex FY 2025 · Dec 31, 2023 $11.8M
Operating Cash Flow FY 2025 · Dec 31, 2025 $200.87M
Operating Cash Flow FY 2025 · Dec 31, 2024 $123.42M
Operating Cash Flow FY 2025 · Dec 31, 2023 −$88.8M
Cash And Equivalents FY 2025 · Dec 31, 2025 $496.3M
Cash And Equivalents FY 2025 · Dec 31, 2024 $344.87M
Stockholders Equity FY 2025 · Dec 31, 2025 $1.22B
Stockholders Equity FY 2025 · Dec 31, 2024 $946.38M
Stockholders Equity FY 2025 · Dec 31, 2023 $778.64M
Stockholders Equity FY 2025 · Dec 31, 2022 $522.23M
Current Liabilities FY 2025 · Dec 31, 2025 $102.94M
Current Liabilities FY 2025 · Dec 31, 2024 $102M
Total Liabilities FY 2025 · Dec 31, 2025 $114.23M
Total Liabilities FY 2025 · Dec 31, 2024 $109.46M
Current Assets FY 2025 · Dec 31, 2025 $1.02B
Current Assets FY 2025 · Dec 31, 2024 $742.05M
Total Assets FY 2025 · Dec 31, 2025 $1.33B
Total Assets FY 2025 · Dec 31, 2024 $1.06B
Eps Diluted FY 2025 · Dec 31, 2025 $6.84
Eps Diluted FY 2025 · Dec 31, 2024 $3.00
Eps Diluted FY 2025 · Dec 31, 2023 $0.39
Eps Basic FY 2025 · Dec 31, 2025 $7.08
Eps Basic FY 2025 · Dec 31, 2024 $3.12
Eps Basic FY 2025 · Dec 31, 2023 $0.40
Sga Expense FY 2025 · Dec 31, 2025 $146.74M
Sga Expense restated FY 2025 · Dec 31, 2024 $113.63M
Sga Expense restated FY 2025 · Dec 31, 2023 $98.29M
Rd Expense FY 2025 · Dec 31, 2025 $58.05M
Rd Expense restated FY 2025 · Dec 31, 2024 $53.58M
Rd Expense restated FY 2025 · Dec 31, 2023 $46.43M
Net Income FY 2025 · Dec 31, 2025 $204.83M
Net Income FY 2025 · Dec 31, 2024 $89.16M
Net Income FY 2025 · Dec 31, 2023 $10.93M
Operating Income FY 2025 · Dec 31, 2025 $161.3M
Operating Income restated FY 2025 · Dec 31, 2024 $65.75M
Operating Income restated FY 2025 · Dec 31, 2023 −$109.62M
Revenue FY 2025 · Dec 31, 2025 $389.13M
Revenue FY 2025 · Dec 31, 2024 $290.52M
Revenue FY 2025 · Dec 31, 2023 $50.7M